Zhang, H., Chen, H., Li, X., Wu, M., Zhu, X., Li, C., . . . Ding, Y. (2021). A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects. Front Pharmacol.
استشهاد بنمط شيكاغوZhang, Hong, et al. "A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects." Front Pharmacol 2021.
MLA استشهادZhang, Hong, et al. "A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects." Front Pharmacol 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.